Pediatric Medical Spending on Mental Health Increased by 31% in 4-Year Period

News
Article

Medical spending on pediatric mental health conditions accounted for 46.6% of all pediatric medical spending in 2021.

In a study that assessed medical spending for children with a mental health condition from 2017-2021, investigators found that pediatric mental health conditions were associated with $4361-higher total medical spending in 2021, a 31.1% increase from 2017.1

Physician holding piggy bank / Andy Dean - stock.adobe.com

Physician holding piggy bank / Andy Dean - stock.adobe.com

The increased prevalence of pediatric mental health conditions, along with the demand for increased services, is growing in the United States, though the associated overall household health care expenditures is unknown, stated the study investigators.

Key Takeaways

  • Medical spending for children with mental health conditions increased by 31% from 2017 to 2021.
  • In 2021, mental health conditions accounted for 46.6% of all pediatric medical spending.
  • Study results suggest that mental health conditions are a growing concern for children and their families, and that the cost of care is also rising.

The cross-sectional study used data from the Medical Expenditure Panel Survey, a nationally representative sample of the United States population containing medical spending, use, and household demographics.

According to the investigators, "[mental health] conditions were identified as diagnoses for any [mental health] condition and also analyzed separately for behavioral disorders, attention-deficit/hyperactivity disorder, anxiety, and depression."1

Among children aged 5 to 17 years, investigators estimated the weighted prevalence of mental health diagnoses and total medical spending from 2017-2021. They estimated segmented generalized linear regression models to compare difference in spending between children with and without a mental health condition.

Another model was estimated using pooled data to determine the differences in spending in total health care, outpatient, inpatient, drug, and emergency department costs associated with each condition. A similar model was repeated to determine differences in spending between households with a child that has a mental health condition and households without.

READ MORE: Antidepressant Dispensing Soared Among Adolescents, Young Adults After COVID-19 Pandemic

Tests were 2-sided with a statistical significance set at P < .05.

According to study data, there was a yearly weighted mean of 9,046,483 children with a mental health condition and 33,922,246 family members (unweighted: 827 children, 3093 families).

Weighted prevalence of mental health diagnoses among children had a relative increase of 21.6%. Overall, total medical spending associated with pediatric mental health conditions were $4361 higher in 2021, representing a 31.1% increase from 2017. In the study period pooled analysis, spending was higher among all categories.

Among household members, pediatric mental health conditions were associated with $2337-higher total medical spending in 2021.

The same year, pediatric mental health conditions were associated with $31 billion in child spending and $59 billion in household spending, which made up 46.6% of all pediatric medical spending that year, according to the study investigators.

Data from the cross-sectional study supports existing literature on the increased prevalence of pediatric mental health diagnoses.

"These results underscore the large financial burden associated with pediatric [mental health] conditions on the US health care system. The associated increase in household member medical spending may warrant family-based approaches to treating pediatric [mental health] conditions," concluded the study authors.

This article originally appeared in Contemporary Pediatrics.

READ MORE: Mental and Behavioral Health Resource Center

Reference
1. Loo TM, Altman M, Bravata DM, Whaley C. Medical spending among US households with children with a mental health condition between 2017 and 2021. JAMA Netw Open. 2024;7(3):e241860. doi:10.1001/jamanetworkopen.2024.1860
Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.